EBITDA: Income before interest, taxes, depreciation and amortization.
UNITY Biotechnology, Inc. (UBX) had EBITDA of $-6.79M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-7.30M |
|
-- |
|
-- |
|
$6.89M |
|
$-6.89M |
|
$-0.41M |
|
$-7.30M |
|
$-7.30M |
|
$-7.30M |
|
$-7.30M |
|
$-7.30M |
|
$-7.30M |
|
$-6.89M |
|
|
EBITDA |
$-6.79M |
16.87M |
|
16.87M |
|
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$17.65M |
|
$3.28M |
|
$12.70M |
|
$30.35M |
|
$9.07M |
|
-- |
|
$21.49M |
|
$30.55M |
|
$-0.20M |
|
$-0.20M |
|
$-0.20M |
|
17.21M |
|
| Cash Flow Statement Financials | |
$-6.36M |
|
$6.78M |
|
-- |
|
$8.48M |
|
$8.89M |
|
$0.42M |
|
$0.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.95 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
3562.06% |
|
3561.95% |
|
-24.06% |
|
3561.95% |
|
$-0.01 |
|
$-0.38 |
|
$-0.38 |
|